Soleus Capital Management, L.P.

Position in CGON — CG Oncology, Inc.

CIK 1802630 GREENWICH, CT

Position in CGON

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$355,250

-$998,350 QoQ

Shares Held

5,000

-75.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#149

of 226 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. CGON ranks #61 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	939,254	$349,092,534
2	CELC	Celcuity Inc.	1,704,318	$178,305,749
3	TGTX	Tg Therapeutics, Inc.	2,927,895	$160,858,551
4	RIGL	Rigel Pharmaceuticals Inc	1,843,504	$72,117,876
5	VCEL	Vericel Corp	1,459,152	$64,917,672
6	PRAX	Praxis Precision Medicines, Inc.	177,517	$59,430,916
7	GERN	Geron Corp	42,808,659	$54,795,083
8	ERAS	Erasca, Inc.	2,700,000	$49,464,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$355,250	5,000	-75.0%	Shares	Sole	2026-08-11
2026-03-31	$1,353,600	20,000	-88.2%	Shares	Sole	2026-05-14
2025-12-31	$7,058,400	170,000	-41.4%	Shares	Sole	2026-02-12
2025-09-30	$11,681,200	290,000	+87.1%	Shares	Sole	2025-11-14
2025-06-30	$4,030,000	155,000	-48.9%	Shares	Sole	2025-08-15
2025-03-31	$7,434,796	303,585	-7.6%	Shares	Sole	2025-05-15
2024-12-31	$9,423,817	328,585	-3.5%	Shares	Sole	2025-02-14
2024-09-30	$12,850,272	340,585	-19.8%	Shares	Sole	2024-11-14
2024-06-30	$13,404,148	424,585	+94.9%	Shares	Sole	2024-08-14
2024-03-31	$9,564,536	217,871	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.